{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:24Z","timestamp":1793442684392,"version":"4.5.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473867"],"award-info":[{"award-number":["82473867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304416"],"award-info":[{"award-number":["82304416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20231016"],"award-info":[{"award-number":["BK20231016"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115364","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:37:15Z","timestamp":1789688235000},"page":"115364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Beyond efficiency: the AI-driven shift toward safer lipid nanoparticles for gene delivery"],"prefix":"10.1016","volume":"399","author":[{"given":"Hai-Xin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Jiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian Wu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu-Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115364_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s44222-026-00401-1","article-title":"Design principles of lipid nanoparticles for RNA delivery","author":"Arral","year":"2026","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2026.115364_bb0010","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115364_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0020","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3390\/vaccines12101148","article-title":"Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2026.115364_bb0025","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3390\/pharmaceutics16121521","article-title":"Effect of lipid nanoparticle physico-chemical properties and composition on their interaction with the immune system","volume":"16","author":"Catenacci","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115364_bb0030","article-title":"Lipid nanoparticles optimized for targeting and release of nucleic acid","volume":"36","author":"Jia","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0035","article-title":"Potent liver-tropic mRNA lipid nanoparticles: ApoE-mediated delivery through a low-density lipoprotein receptor independent uptake mechanism","author":"Sarode","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0040","article-title":"Physiological barriers and strategies of lipid-based nanoparticles for nucleic acid drug delivery","volume":"36","author":"Hu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114977","article-title":"Subcellular visualization: organelle-specific targeted drug delivery and discovery","volume":"199","author":"Shao","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115364_bb0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115364_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201695","article-title":"Understanding intracellular biology to improve mRNA delivery by lipid nanoparticles","volume":"7","author":"Hunter","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2026.115364_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202511551","article-title":"High-throughput strategies for streamlining lipid nanoparticle development pipeline","volume":"12","author":"Lam","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0065","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41587-024-02490-y","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","volume":"43","author":"Witten","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115364_bb0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D1BM01454D","article-title":"Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)","volume":"10","author":"\u00c1lvarez-Benedicto","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115364_bb0085","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1021\/acs.langmuir.1c00319","article-title":"Fusogenic effect of cholesterol prevails over the inhibitory effect of a peptide-based membrane fusion inhibitor","volume":"37","author":"Pattnaik","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2026.115364_bb0090","article-title":"Exploring precision treatments in immune-mediated inflammatory diseases: harnessing the infinite potential of nucleic acid delivery","volume":"5","author":"Xu","year":"2025","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.jconrel.2026.115364_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and parmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115364_bb0100","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.115364_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.567365","article-title":"Opsonins and dysopsonins of nanoparticles: facts, concepts, and methodological guidelines","volume":"11","author":"Papini","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11070327","article-title":"Chemistry routes for copolymer synthesis containing PEG for targeting, imaging, and drug delivery purposes","volume":"11","author":"Rahme","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115364_bb0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115364_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12951-025-03209-0","article-title":"Emerging strategies against accelerated blood clearance phenomenon of nanocarrier drug delivery systems","volume":"23","author":"Pan","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0125","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41565-021-01001-3","article-title":"The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines","volume":"16","author":"Bigini","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0135","article-title":"mRNA delivery systems 2.0: engineering extrahepatic delivery for non-vaccine therapeutics","volume":"35","author":"Dalabehera","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115364_bb0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-025-01124-x","article-title":"Ionizable lipid nanoparticles of mRNA vaccines elicit NF-\u03baB and IRF responses through toll-like receptor 4","volume":"10","author":"Zelkoski","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2026.115364_bb0145","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0150","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1016\/j.cell.2025.11.023","article-title":"Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses","volume":"188","author":"Casta\u00f1o","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115364_bb0155","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41565-025-01974-5","article-title":"Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape","volume":"20","author":"Omo-Lamai","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114635","article-title":"Protein corona: friend or foe? Co-opting serum proteins for nanoparticle delivery","volume":"192","author":"Kim","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115364_bb0165","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/acs.molpharmaceut.2c00033","article-title":"Comparison of DLin-MC3-DMA and ALC-0315 for siRNA delivery to hepatocytes and hepatic stellate cells","volume":"19","author":"Ferraresso","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115364_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215179","article-title":"Spermidine\/Spermine N1-acetyltransferase 1 (SAT1)-a potential gene target for selective sensitization of glioblastoma cells using an ionizable lipid nanoparticle to deliver siRNA","volume":"14","author":"Yathindranath","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115364_bb0175","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115364_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115364_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41580-019-0177-4","article-title":"The many functions of ESCRTs","volume":"21","author":"Vietri","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0190","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.216499","article-title":"The enigmatic endosome - sorting the ins and outs of endocytic trafficking","volume":"131","author":"Naslavsky","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0195","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.15252\/embj.201591481","article-title":"ER-endosome contact sites: molecular compositions and functions","volume":"34","author":"Raiborg","year":"2015","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115364_bb0200","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202102001","article-title":"Lysosome biogenesis: regulation and functions","volume":"220","author":"Yang","year":"2021","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202411720","article-title":"Organelle-targeting nanoparticles","volume":"12","author":"Soukar","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102172","article-title":"Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics","volume":"70","author":"Kaur","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0215","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","article-title":"Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d","volume":"8","author":"Chaudhary","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115364_bb0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13036-025-00573-1","article-title":"Integration of TLR7\/8 agonists into lipid nanoparticles enhances antigen-specific immune responses to N1-methyl-\u03a8-modified mRNA-LNP vaccines","volume":"19","author":"Choi","year":"2025","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.jconrel.2026.115364_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads4539","article-title":"Exogenous RNA surveillance by proton-sensing TRIM25","volume":"388","author":"Kim","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115364_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122062","article-title":"Nanovaccine that activates the NLRP3 inflammasome enhances tumor specific activation of anti-cancer immunity","volume":"296","author":"Manna","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115364_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107771","article-title":"Transcriptional control of interferon-stimulated genes","volume":"300","author":"Babadei","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115364_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119792","article-title":"PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: faster PEG shedding attenuates anti-PEG IgM production","volume":"588","author":"Suzuki","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115364_bb0245","doi-asserted-by":"crossref","first-page":"17780","DOI":"10.1021\/acsnano.6c07672","article-title":"Hydroxyl-terminated polyethylene glycol evades human pre-existing anti-polyethylene glycol antibodies","volume":"20","author":"Ding","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115364_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082068","article-title":"Polysarcosine-functionalized mRNA lipid nanoparticles tailored for immunotherapy","volume":"15","author":"Wilhelmy","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115364_bb0260","doi-asserted-by":"crossref","first-page":"41248","DOI":"10.1021\/jacs.5c16448","article-title":"Glycolipids substitute PEG lipids in lipid nanoparticles for mRNA delivery","volume":"147","author":"Jin","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115364_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124695","article-title":"Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery","volume":"665","author":"Hassanel","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115364_bb0270","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s41563-024-02116-3","article-title":"High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics","volume":"24","author":"Xiao","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0275","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115364_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114267","article-title":"Hydroxychloroquine-functionalized ionizable lipids mitigate inflammatory responses in mRNA therapeutics","volume":"387","author":"Chen","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01577-4","article-title":"Low reactogenicity and high tumour antigen expression from mRNA-LNPs with membrane-destabilizing zwitterionic lipids","author":"Zhao","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115364_bb0290","doi-asserted-by":"crossref","first-page":"34449","DOI":"10.1021\/jacs.5c08376","article-title":"Strain-promoted mRNA transdermal delivery by lipoic lipid nanoparticles for therapeutic skin genome editing","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115364_bb0295","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115364_bb0300","article-title":"STING-activating polymers boost lymphatic delivery of mRNA vaccine to potentiate cancer immunotherapy","volume":"37","author":"Zhang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0305","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.7150\/thno.121364","article-title":"Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathways","volume":"16","author":"Chiang","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115364_bb0310","article-title":"Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids","author":"Patel","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102502","article-title":"Inhibition of IFNAR-JAK signaling enhances tolerability and transgene expression of systemic non-viral DNA delivery","volume":"36","author":"Senapati","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115364_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114736","article-title":"Formulation and administration timing of lipid derivatized JAK-inhibitor and corticosteroid modulate saRNA-LNP inflammation and expression","volume":"392","author":"Bathula","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0325","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41541-025-01263-1","article-title":"Synergistic effect of nucleoside modification and ionizable lipid composition on translation and immune responses to mRNA vaccines","volume":"10","author":"Danz","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2026.115364_bb0330","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1021\/acs.accounts.1c00550","article-title":"Lipid nanoparticle-mRNA formulations for therapeutic applications","volume":"54","author":"Wang","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2026.115364_bb0335","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41587-024-02174-7","article-title":"Branched chemically modified poly(a) tails enhance the translation capacity of mRNA","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0340","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0345","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce the risks of mRNA drug and vaccine toxicity","volume":"23","author":"Bitounis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115364_bb0350","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1021\/acsnano.5c22020","article-title":"Immune modulatory oxysterols produced from cholesterol-containing lipid nanoparticles regulate tumor growth","volume":"20","author":"Back","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0355","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","article-title":"Lipid nanoparticle technology for therapeutic gene regulation in the liver","volume":"159","author":"Witzigmann","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115364_bb0360","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jconrel.2024.05.007","article-title":"Spleen-targeted delivery systems and strategies for spleen-related diseases","volume":"370","author":"Huang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0365","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0375","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0380","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0385","doi-asserted-by":"crossref","first-page":"41756","DOI":"10.1021\/jacs.5c13982","article-title":"Fluorinated ionizable lipids for efficient spleen-targeted mRNA delivery in cancer immunotherapy","volume":"147","author":"Zhang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115364_bb0390","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady6460","article-title":"Replacing cholesterol and PEGylated lipids with zwitterionic ionizable lipids in LNPs for spleen-specific mRNA translation","volume":"11","author":"Zhao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115364_bb0395","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113687","article-title":"Splenic B cell-targeting lipid nanoparticles for safe and effective mRNA vaccine delivery","volume":"382","author":"Suzuki","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202515480","article-title":"Targeting DNA-LNPs to endothelial cells improves expression magnitude, duration, and specificity","volume":"13","author":"Marzolini","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0410","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1021\/acschembio.0c00003","article-title":"Engineering caveolae-targeted lipid nanoparticles to deliver mRNA to the lungs","volume":"15","author":"Li","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0415","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molmed.2023.02.004","article-title":"Brain gene therapy with Trojan horse lipid nanoparticles","volume":"29","author":"Pardridge","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"15(6)","key":"10.1016\/j.jconrel.2026.115364_bb0420","article-title":"Increased bone marrow uptake and accumulation of very-late antigen-4 targeted lipid nanoparticles","volume":"15","author":"Swart","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115364_bb0425","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12951-025-03225-0","article-title":"Specific muscle targeted delivery of miR-130a loaded lipid nanoparticles: a novel approach to inhibit lipid accumulation in skeletal muscle and obesity","volume":"23","author":"Wang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0430","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1039\/D2BM00447J","article-title":"Membrane-wrapped nanoparticles for nucleic acid delivery","volume":"10","author":"Scully","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101202","article-title":"Functional siRNA delivery by extracellular vesicle-liposome hybrid nanoparticles","volume":"11","author":"Evers","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0440","doi-asserted-by":"crossref","first-page":"15668","DOI":"10.1021\/acsnano.4c18153","article-title":"Chimeric antigen receptor-engineered cell membrane-coated nanoparticles promote dual-targeted mRNA-based cancer gene therapy","volume":"19","author":"Lei","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0445","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1021\/acsbiomaterials.8b00858","article-title":"siRNA delivery with stem cell membrane-coated magnetic nanoparticles for imaging-guided photothermal therapy and gene therapy","volume":"4","author":"Mu","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2026.115364_bb0450","doi-asserted-by":"crossref","first-page":"17074","DOI":"10.1021\/acs.nanolett.5c04371","article-title":"Bacterial membrane coating potentiates lipid nanoparticles for mRNA delivery","volume":"25","author":"Wang","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115364_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk9754","article-title":"Biofunctional lipid nanoparticles for precision treatment and prophylaxis of bacterial infections","volume":"10","author":"Peng","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115364_bb0460","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/acs.biochem.3c00371","article-title":"Lipid nanoparticles deliver mRNA to the brain after an intracerebral injection","volume":"62","author":"Tuma","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2026.115364_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309225","article-title":"Nanoparticle-mediated delivery of anti-PU.1 siRNA via localized intracisternal administration reduces neuroinflammation","volume":"36","author":"Ralvenius","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0470","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2022.03.021","article-title":"Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy","volume":"345","author":"Liu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106370","article-title":"Lipid nanoparticle-mediated mRNA delivery in lung fibrosis","volume":"183","author":"Massaro","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0480","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007421","article-title":"Materials for improving immune cell transfection","volume":"33","author":"Kumar","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0485","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1158\/0008-5472.CAN-10-2880","article-title":"Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115364_bb0490","doi-asserted-by":"crossref","first-page":"8751","DOI":"10.1021\/acsnano.1c07648","article-title":"Probing the intracellular delivery of nanoparticles into hard-to-transfect cells","volume":"16","author":"Yang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102773","article-title":"Myeloid cell-targeted lipid nanoparticles for B cell lymphoma immunotherapy","volume":"36","author":"Kang","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115364_bb0500","article-title":"A combinatorial library of lipid nanoparticles for cell type-specific mRNA delivery","volume":"10","author":"Naidu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0505","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202470228","article-title":"Tumor-tailored ionizable lipid nanoparticles facilitate IL-12 circular RNA delivery for enhanced lung cancer immunotherapy","volume":"36","author":"Xu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0510","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady5579","article-title":"A multistep platform identifies spleen-tropic lipid nanoparticles for in vivo T cell-targeted delivery of gene-editing proteins","volume":"11","author":"Lu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115364_bb0515","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-025-01759-2","article-title":"In vivo CAR cell therapy: from bench to bedside","volume":"18","author":"Xu","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0520","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","article-title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs","volume":"29","author":"Tomb\u00e1cz","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115364_bb0525","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115364_bb0530","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.ymthe.2025.03.018","article-title":"CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery","volume":"33","author":"Papp","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115364_bb0535","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1021\/acsnano.4c16562","article-title":"Apolipoprotein fusion enables spontaneous functionalization of mRNA lipid nanoparticles with antibody for targeted cancer therapy","volume":"19","author":"Park","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0540","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.addr.2016.05.009","article-title":"Tumor-targeting peptides from combinatorial libraries","volume":"110-111","author":"Liu","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115364_bb0545","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fimmu.2015.00135","article-title":"Modulation of CD44 activity by A6-peptide","volume":"6","author":"Finlayson","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0550","doi-asserted-by":"crossref","first-page":"13685","DOI":"10.1021\/acsnano.4c14625","article-title":"Peptide-modified lipid nanoparticles boost the antitumor efficacy of RNA therapeutics","volume":"19","author":"Zhao","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0555","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/acsnano.3c10109","article-title":"mRNA-laden lipid-nanoparticle-enabled in situ CAR-macrophage engineering for the eradication of multidrug-resistant bacteria in a sepsis mouse model","volume":"18","author":"Tang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0560","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.ymthe.2025.01.037","article-title":"PBAE-PEG-based lipid nanoparticles for lung cell-specific gene delivery","volume":"33","author":"Liu","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115364_bb0565","article-title":"Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115364_bb0570","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1038\/s41467-024-51571-8","article-title":"RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment","volume":"15","author":"Shan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0575","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.1016\/j.addr.2023.115051","article-title":"Progress on the pathological tissue microenvironment barrier-modulated nanomedicine","volume":"200","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115364_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119616","article-title":"Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy","volume":"230","author":"Fan","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115364_bb0585","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg5358","article-title":"Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice","volume":"9","author":"Han","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115364_bb0590","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jconrel.2022.09.054","article-title":"Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy","volume":"351","author":"Yang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121945","article-title":"Remodeling of imbalanced extracellular matrix homeostasis for reversal of pancreatic fibrosis","volume":"292","author":"Qi","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115364_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114278","article-title":"Fibrotic collagen-targeted delivery system blocks pancreatic intercellular crosstalk to alleviate pancreatic fibrosis","volume":"388","author":"Wang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0605","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/s41467-024-51056-8","article-title":"Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0610","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409812","article-title":"Simplified lipid nanoparticles for tissue- and cell-targeted mRNA delivery facilitate precision tumor therapy in a lung metastasis mouse model","volume":"36","author":"Fei","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0615","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1038\/s41467-023-43065-w","article-title":"Rational design of microRNA-responsive switch for programmable translational control in mammalian cells","volume":"14","author":"Ning","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0620","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nbt.3298","article-title":"Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown","volume":"33","author":"Wittrup","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0625","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0630","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: a bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0635","article-title":"A perspective of lipid nanoparticles for RNA delivery","volume":"4","author":"Ma","year":"2024","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.jconrel.2026.115364_bb0640","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0645","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2018.05.034","article-title":"The proton sponge hypothesis: fable or fact?","volume":"129","author":"Vermeulen","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115364_bb0650","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/s41565-025-02044-6","article-title":"Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines","volume":"20","author":"Rudra","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0655","doi-asserted-by":"crossref","first-page":"29416","DOI":"10.1021\/acsnano.5c07140","article-title":"Effective RNA delivery with aggregation-induced lipid backfolding","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0660","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0665","article-title":"Boosting mRNA therapeutics: pHLIP enhances endosomal escape and gene expression in lipid nanoparticle","author":"Liu","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0670","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s41565-024-01765-4","article-title":"Acid-degradable lipid nanoparticles enhance the delivery of mRNA","volume":"19","author":"Zhao","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0675","article-title":"Engineered lipid nanoparticles with synergistic dendritic cell targeting and enhanced endosomal escape for boosted mRNA cancer vaccines","volume":"34","author":"Wang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115364_bb0680","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.11.046","article-title":"Enhanced nuclear gene delivery via integrating and streamlining intracellular pathway","volume":"341","author":"Qi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0685","doi-asserted-by":"crossref","first-page":"31530","DOI":"10.1021\/jacs.5c05367","article-title":"Breaking endosomal barriers: thiol-mediated uptake lipid nanoparticles for efficient mRNA vaccine delivery","volume":"147","author":"Lian","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115364_bb0690","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jcis.2023.10.039","article-title":"The power of sulfhydryl groups: thiolated lipid-based nanoparticles enhance cellular uptake of nucleic acids","volume":"654","author":"Stengel","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2026.115364_bb0695","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202502231","article-title":"Bypassing endocytic barriers: visualizing membrane fusion and endosomal escape of cubic phase lipid nanoparticles (cubosomes)","volume":"21","author":"Yap","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115364_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117413","article-title":"The siEGFR nanoplexes for the enhanced brain glioma treatment: endoplasmic reticulum biomimetic strategy to induce homing effect and non-degradable intracellular transport","volume":"179","author":"Tu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.115364_bb0705","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202110137","article-title":"Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale","volume":"221","author":"Paramasivam","year":"2022","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0710","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jconrel.2022.05.020","article-title":"Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells","volume":"347","author":"Patel","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0715","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0720","doi-asserted-by":"crossref","first-page":"20163","DOI":"10.1021\/acsnano.2c04829","article-title":"Interaction kinetics of individual mRNA-containing lipid nanoparticles with an endosomal membrane mimic: dependence on pH, protein corona formation, and lipoprotein depletion","volume":"16","author":"Aliakbarinodehi","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0725","doi-asserted-by":"crossref","first-page":"64219","DOI":"10.1021\/acsami.5c17052","article-title":"Effects of serum incubation on lipid nanoparticle PEG shedding, mRNA retention, and membrane interactions","volume":"17","author":"Niederkofler","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115364_bb0730","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","article-title":"Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles","volume":"15","author":"Sebastiani","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0735","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrd.2018.174","article-title":"Mitochondria as a therapeutic target for common pathologies","volume":"17","author":"Murphy","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115364_bb0740","article-title":"Recent advances in mitochondria-targeting theranostic agents","volume":"4","author":"Qian","year":"2024","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.jconrel.2026.115364_bb0745","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","article-title":"Mitochondria and cell death","volume":"26","author":"Glover","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0750","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41580-021-00332-2","article-title":"Mechanisms and regulation of protein synthesis in mitochondria","volume":"22","author":"Kummer","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0755","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.molmed.2010.04.007","article-title":"Therapeutic prospects for mitochondrial disease","volume":"16","author":"Schon","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115364_bb0760","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(11)61305-6","article-title":"Mitochondrial diseases","volume":"379","author":"Schapira","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.115364_bb0765","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41392-024-02081-y","article-title":"Engineered mitochondria in diseases: mechanisms, strategies, and applications","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115364_bb0770","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-022-00715-9","article-title":"Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges","volume":"18","author":"Falabella","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115355","article-title":"Mitochondrial endogenous substance transport-inspired nanomaterials for mitochondria-targeted gene delivery","volume":"211","author":"Wang","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115364_bb0780","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","article-title":"The cell biology of mitochondrial membrane dynamics","volume":"21","author":"Giacomello","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0785","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1038\/s41467-018-05615-5","article-title":"Control of transmembrane charge transfer in cytochrome c oxidase by the membrane potential","volume":"9","author":"Bj\u00f6rck","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0790","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.addr.2020.09.010","article-title":"Power of mitochondrial drug delivery systems to produce innovative nanomedicines","volume":"154-155","author":"Yamada","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115364_bb0795","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1017\/S1431927611000249","article-title":"Staining of mitochondria with Cy5-labeled oligonucleotides for long-term microscopy studies","volume":"17","author":"Lorenz","year":"2011","journal-title":"Microsc. Microanal."},{"key":"10.1016\/j.jconrel.2026.115364_bb0800","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","article-title":"Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output","volume":"183","author":"Zhao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115364_bb0805","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/s41467-021-22594-2","article-title":"Mitochondrion-specific dendritic lipopeptide liposomes for targeted sub-cellular delivery","volume":"12","author":"Jiang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0810","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbamem.2007.11.002","article-title":"MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion","volume":"1778","author":"Yamada","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2026.115364_bb0815","article-title":"Pathologically responsive mitochondrial gene therapy in an allotopic expression-independent manner cures Leber's hereditary optic neuropathy","volume":"33","author":"Wang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0820","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1038\/s41467-025-65874-x","article-title":"Mitochondria-targeted gene delivery using fluorinated lipid nanoparticles to alleviate Leber's hereditary optic neuropathy","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0825","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/acs.accounts.1c00766","article-title":"Fluorination promotes the cytosolic delivery of genes, proteins, and peptides","volume":"55","author":"Lv","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2026.115364_bb0830","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.1038\/s41467-025-64813-0","article-title":"A mitochondria-targeted fluoropolymer nanoparticle with inherent mitophagy-inducing and red fluorescence properties for treatment of atherosclerosis","volume":"16","author":"Liang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0835","doi-asserted-by":"crossref","DOI":"10.1126\/science.adr3498","article-title":"Silencing mitochondrial gene expression in living cells","volume":"389","author":"Cruz-Zaragoza","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115364_bb0840","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1074\/jbc.275.3.1625","article-title":"Size-dependent DNA mobility in cytoplasm and nucleus","volume":"275","author":"Lukacs","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115364_bb0845","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrm1230","article-title":"The nuclear pore complex: nucleocytoplasmic transport and beyond","volume":"4","author":"Fahrenkrog","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0850","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3390\/cells12121637","article-title":"Nuclear delivery of nanoparticle-based drug delivery systems by nuclear localization signals","volume":"12","author":"Nie","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115364_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121735","article-title":"Nuclear targeting subcellular-delivery nanosystems for precise cancer treatment","volume":"619","author":"Du","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115364_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124492","article-title":"Inclusion of TAT and NLS sequences in lipopeptide molecules generates homogenous nanoparticles for gene delivery applications","volume":"662","author":"Tarwadi","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115364_bb0865","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1021\/acsnano.6b08345","article-title":"Nuclear membrane-targeted gold nanoparticles inhibit cancer cell migration and invasion","volume":"11","author":"Ali","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0870","doi-asserted-by":"crossref","first-page":"18249","DOI":"10.1039\/D0NR03156A","article-title":"Targeting DNA to the endoplasmic reticulum efficiently enhances gene delivery and therapy","volume":"12","author":"Qin","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115364_bb0875","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1038\/s41467-019-10562-w","article-title":"Regulating intracellular fate of siRNA by endoplasmic reticulum membrane-decorated hybrid nanoplexes","volume":"10","author":"Qiu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0880","doi-asserted-by":"crossref","first-page":"28735","DOI":"10.1021\/acsnano.4c07615","article-title":"Machine learning elucidates design features of plasmid deoxyribonucleic acid lipid nanoparticles for cell type-preferential transfection","volume":"18","author":"Cheng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115364_bb0885","article-title":"Rational design of lipid nanoparticles for enhanced mRNA vaccine delivery via machine learning","volume":"21","author":"Bae","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115364_bb0890","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jconrel.2024.10.047","article-title":"Optimizing lipid nanoparticles for fetal gene delivery in vitro, ex vivo, and aided with machine learning","volume":"376","author":"Abostait","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115364_bb0895","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-026-01640-8","article-title":"Artificial intelligence-guided design of LNPs for in vivo targeted mRNA delivery via analysis of the spatial conformation of ionizable lipids","author":"Su","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115364_bb0900","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202526278","article-title":"Controlling payload heterogeneity in lipid nanoparticles for RNA-based therapeutics","author":"Pial","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0905","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","article-title":"Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry","volume":"23","author":"Li","year":"2024","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0910","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1038\/s41467-024-50619-z","article-title":"AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0915","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1038\/s41467-024-55072-6","article-title":"Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115364_bb0920","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41565-025-01975-4","article-title":"Designing lipid nanoparticles using a transformer-based neural network","volume":"20","author":"Chan","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115364_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.100996","article-title":"Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost\/Bayesian method and ensemble model approaches","volume":"14","author":"Maharjan","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jconrel.2026.115364_bb0930","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41563-025-02331-6","article-title":"Peptide codes for organ-selective mRNA delivery","volume":"25","author":"Chang","year":"2026","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0935","doi-asserted-by":"crossref","first-page":"38865","DOI":"10.1021\/jacs.5c14870","article-title":"Computationally aided design of ionizable cholesteryl lipids for lipid nanoparticles to modulate hepatic mRNA accumulation","volume":"147","author":"Teng","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115364_bb0940","article-title":"An inherent T cell-activating mRNA delivery carrier for in vivo CAR T generation","author":"Cao","year":"2026","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115364_bb0945","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.cell.2026.01.012","article-title":"LUMI-lab: a foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery","volume":"189","author":"Xu","year":"2026","journal-title":"Cell"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:44:58Z","timestamp":1793439898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926007686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":189,"alternative-id":["S0168365926007686"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115364","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond efficiency: the AI-driven shift toward safer lipid nanoparticles for gene delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115364"}}